Singapore Court of Appeal Notes No Finding of Fraud Against KBP or Dr. Huang; Dispute with Novo Nordisk Undergoing Arbitration Proceedings
SINGAPORE, May 21, 2026 /PRNewswire/ — KBP Biosciences Pte. Ltd. (the “Company” or “KBP”) today issued a statement…